IL-6 Biomarker for Sepsis Detection in Babies, Kids, and Moms
What: Researchers presented findings showing IL-6 could outperform traditional inflammatory markers in early sepsis detection among newborns, children, and pregnant women.
Key Line: “This faster, steeper response makes IL-6 a promising biomarker for earlier sepsis detection.”
Source: ESCMID
The New York Times dives into the ethics and limitations of using polygenic screening in IVF, highlighting the probabilistic nature of the predictions.
The U.S. Supreme Court appears inclined to allow Medicaid patients to continue receiving non-abortion care from Planned Parenthood.
Legislators push for regulation and oversight of anti-abortion pregnancy centers.
Women’s health startups raised $2.6B in VC funding last year, but exits remain elusive.
Mouse study reveals female hormones help trigger opioid production in spinal cord immune cells.
Mother Jones covers the arrest of a midwife in Texas and the ongoing dangers of the state’s abortion bans.
A new study finds fasting three days a week more effective than daily calorie restriction for weight loss.
Promising cancer immunotherapy study delayed due to NIH layoffs.
New data reveals most U.S. teen girls live under abortion restrictions.
A review on how abortion rates increased after Roe v. Wade was overturned.
The 19th highlights how removing “DEI” efforts puts research on women’s health at risk.
Study finds no added benefit from multi-drug regimens for women with heart pain but no artery blockage.
New report calls women’s health a $360B ‘ghost market’ full of unmet needs across menopause, sexual health, aging, and more.
New York Times honors the woman who funded and enabled the development of the birth control pill.
Ashley Parker writes about the emotional and medical realities of miscarriage, including how the term “abortion” appears in routine procedures.
JAMA study shows a 28% increase in maternal deaths from 2018 to 2022.
A blood test may soon predict postpartum depression before symptoms arise.
The administration froze $35 million in Title X funding, reducing access to birth control and screenings for millions.
Critical care doctors reveal fatal consequences of abortion bans in new interviews.
Marty Makary faces controversies as the new FDA commissioner.